26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Diabetes Treatment and Management
Heart Failure Treatment and Management
Diabetes
Cardiovascular Risks
and Lipoproteins
Publication details
- Journal / source
- Journal of the American College of Cardiology
- Volume
- 87
- Issue
- 13
- Pages
- A181–A182
- Publication date
- 27 March 2026
- Language
- EN